Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy

• Status: Completed
• Trial end date: 2010-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having percutaneous nephrolithotomy for kidney stone disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mayo Clinic
• Treatments: Ketorolac; Ketorolac Tromethamine

Criteria

Inclusion Criteria:

• Patients undergoing percutaneous nephrolithotomy for kidney stone disease

Exclusion Criteria:

• History of nonsteroidal antiinflammatory drug allergy

• Asthma

• History of long-term opioid use

• Intraoperative blood loss greater than 300 mL

• Postoperative hemodynamic instability

• Active peptic ulcer disease

• Advanced renal impairment (Creatinine > 2.0 mg/dL)

• Bleeding diathesis

• Current use of probenecid

• Pregnancy